Elke Pogge von Strandmann

Elke Pogge von Strandmann

UNVERIFIED PROFILE

Are you Elke Pogge von Strandmann?   Register this Author

Register author
Elke Pogge von Strandmann

Elke Pogge von Strandmann

Publications by authors named "Elke Pogge von Strandmann"

Are you Elke Pogge von Strandmann?   Register this Author

59Publications

620Reads

Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype.

Front Immunol 2018 18;9:1358. Epub 2018 Jun 18.

Clinic for Hematology, Oncology and Immunology, Experimental Tumor Research, Center for Tumor Biology and Immunology, Philipps University, Marburg, Germany.

View Article
June 2018

Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance.

Philos Trans R Soc Lond B Biol Sci 2018 Jan;373(1737)

Experimental Tumor Research, Center for Tumor Biology and Immunology, Clinic for Hematology, Oncology and Immunology, Philipps University, Hans-Meerwein-Street 3, 35043 Marburg, Germany

View Article
January 2018

Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.

Neurotox Res 2017 Nov 13;32(4):555-562. Epub 2017 Jun 13.

Department of Neurology, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

View Article
November 2017

Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.

Oncoimmunology 2017 21;6(9):e1339854. Epub 2017 Aug 21.

Experimental Tumor Research, Center for Tumor Biology and Immunology, Clinic for Hematology, Oncology and Immunology, Philipps University, Marburg, Germany.

View Article
August 2017

Evidence of Inbreeding in Hodgkin Lymphoma.

PLoS One 2016 28;11(4):e0154259. Epub 2016 Apr 28.

German Cancer Research Center (DKFZ), Division of Molecular Genetic Epidemiology (C050), Heidelberg, 69120, Germany.

View Article
March 2017

The Unique Molecular and Cellular Microenvironment of Ovarian Cancer.

Front Oncol 2017 22;7:24. Epub 2017 Feb 22.

Institute of Molecular Biology and Tumor Research, Center for Tumor Biology and Immunology, Philipps University , Marburg , Germany.

View Article
February 2017

Antigen Loss Variants: Catching Hold of Escaping Foes.

Front Immunol 2017 24;8:175. Epub 2017 Feb 24.

Experimental Tumor Research, Center for Tumor Biology and Immunology, Clinic for Hematology, Oncology and Immunology, Philipps University , Marburg , Germany.

View Article
February 2017

Tumor-Host Cell Interactions in Ovarian Cancer: Pathways to Therapy Failure.

Trends Cancer 2017 02 18;3(2):137-148. Epub 2017 Jan 18.

Institute of Molecular Biology and Tumor Research, Center for Tumor Biology and Immunology (ZTI), Philipps University, Hans-Meerwein-Strasse 3, 35043 Marburg, Germany. Electronic address:

View Article
February 2017

Shipping Drug Resistance: Extracellular Vesicles in Ovarian Cancer.

Trends Mol Med 2016 09 26;22(9):741-743. Epub 2016 Jul 26.

Institute of Molecular Biology and Tumor Research, Center for Tumor Biology and Immunology, Philipps University, Hans-Meerwein-Strasse 3, 35043 Marburg, Germany.

View Article
September 2016

Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity and against chronic lymphocytic leukemia.

Oncoimmunology 2016 15;5(9):e1211220. Epub 2016 Jul 15.

Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany; Experimental Tumor Research, Center for Tumor Biology and Immunology, Philipps University Marburg, Marburg, Germany.

View Article
July 2016

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

Oncoimmunology 2016 Apr 12;5(4):e1071008. Epub 2015 Aug 12.

Gustave Roussy Cancer Campus, Villejuif, France; Laboratoire d'Immunomonitoring en Oncologie, UMS 3655 CNRS / US 23 INSERM Gustave Roussy Cancer Campus, Villejuif, France; Centre d'Investigation Clinique en Biothérapies (CICBT) 1428, Villejuif, France; Laboratoire de Thérapie Cellulaire, Gustave Roussy Cancer Campus, Villejuif, France.

View Article
April 2016

Cetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids.

Front Immunol 2015 2;6:543. Epub 2015 Nov 2.

Institute of Cellular Therapeutics, Integrated Research and Treatment Center Transplantation (IFB-Tx), Hannover Medical School , Hannover , Germany.

View Article
November 2015

NKp30 and its ligands: emerging players in tumor immune evasion from natural killer cells.

Ann Transl Med 2015 Nov;3(20):314

Department I of Internal Medicine, University of Cologne, Cologne, Germany.

View Article
November 2015

Heritability estimates on Hodgkin's lymphoma: a genomic- versus population-based approach.

Eur J Hum Genet 2015 Jun 17;23(6):824-30. Epub 2014 Sep 17.

1] German Cancer Research Center (DKFZ), Division of Molecular Genetic Epidemiology, Heidelberg, Germany [2] Center for Primary Health Care Research, Lund University, Malmö, Sweden.

View Article
June 2015

DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies.

Front Genet 2015 4;6:11. Epub 2015 Feb 4.

Innate Immunity Group, Clinic 1 for Internal Medicine, University of Cologne , Cologne, Germany.

View Article
February 2015

The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.

PLoS One 2013 21;8(11):e79502. Epub 2013 Nov 21.

Department I of Internal Medicine, Innate Immunity Group, University Clinic Cologne, Cologne, Germany.

View Article
September 2014

Role of Exosomes Released by Dendritic Cells and/or by Tumor Targets: Regulation of NK Cell Plasticity.

Front Immunol 2014 7;5:91. Epub 2014 Mar 7.

Clinic I for Internal Medicine, University of Cologne , Cologne , Germany.

View Article
June 2014

Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancer.

Trends Mol Med 2014 Feb 19;20(2):72-82. Epub 2013 Nov 19.

University of Cologne, Clinic 1 for Internal Medicine, 50924 Cologne, Germany. Electronic address:

View Article
February 2014

Regulation of self-ligands for activating natural killer cell receptors.

Ann Med 2013 Jun 23;45(4):384-94. Epub 2013 May 23.

Immunology Programme, Centre for Life Sciences, Department of Microbiology, National University of Singapore 117456, Singapore.

View Article
June 2013

Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma.

Blood 2013 Apr 26;121(17):3431-3. Epub 2013 Feb 26.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.

View Article
April 2013

Rescue of impaired NK cell activity in hodgkin lymphoma with bispecific antibodies in vitro and in patients.

Mol Ther 2013 Apr 5;21(4):895-903. Epub 2013 Mar 5.

Department I of Internal Medicine, Laboratory of Immunotherapy, University Clinic of Cologne, Cologne, Germany.

View Article
April 2013

Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma.

Am J Hematol 2013 Feb 8;88(2):113-5. Epub 2012 Dec 8.

Department of Internal Medicine I, Laboratory for Immunotherapy, University Hospital Cologne, Cologne, Germany.

View Article
February 2013

A novel role for reciprocal CD30-CD30L signaling in the cross-talk between natural killer and dendritic cells.

Biol Chem 2012 Jan;393(1-2):101-6

Laboratory of Immunotherapy, Department I of Internal Medicine, University Clinic of Cologne, Kerpener Strasse 62, 50924 Cologne, Germany.

View Article
January 2012

Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance.

J Innate Immun 2011 11;3(4):344-54. Epub 2011 May 11.

Institute of Biomedical Research, Georg-Speyer-Haus, Frankfurt am Main, Germany.

View Article
October 2011

A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation.

Transpl Immunol 2010 Aug 8;23(4):215-9. Epub 2010 Jul 8.

University Hospital Cologne, Klinik I für Innere Medizin, Stem Cell Transplant Program, Kerpener Str. 62, 50937 Cologne, Germany.

View Article
August 2010

Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphoma.

J Immunother 2009 Jun;32(5):508-12

Laboratory of Immunotherapy, Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.

View Article
June 2009

Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function.

PLoS One 2008 13;3(10):e3377. Epub 2008 Oct 13.

Laboratory of Immune Therapy, Department of Internal Medicine I, Centre for Integrated Oncology Koeln Bonn, University of Cologne, Cologne, Germany.

View Article
December 2008

Simvastatin-dependent apoptosis in Hodgkin's lymphoma cells and growth impairment of human Hodgkin's tumors in vivo.

Haematologica 2007 May;92(5):682-5

Laboratory of Immunotherapy, Clinic I of Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article
May 2007

ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro.

Cancer Res 2007 Jan;67(1):332-8

Department of Internal Medicine I and Center for Molecular Medicine, University Hospital Cologne, Kerpener Strasse 62, 50924 Cologne, Germany.

View Article
January 2007

The fully human anti-CD30 antibody 5F11 activates NF-{kappa}B and sensitizes lymphoma cells to bortezomib-induced apoptosis.

Blood 2005 Sep 5;106(5):1839-42. Epub 2005 May 5.

University Hospital of Cologne, Department of Internal Medicine, Kerpener Str. 62 D-50924 Köln, Germany.

View Article
September 2005

The ectodomain shedding of CD30 is specifically regulated by peptide motifs in its cysteine-rich domains 2 and 5.

FASEB J 2004 May 19;18(7):893-5. Epub 2004 Mar 19.

Department of Internal Medicine I, University Hospital Cologne, LFI, Ebene 4, Room 703, Joseph-Stelzmann-Str. 9, 50924 Cologne, Germany.

View Article
May 2004

Depletion of cellular cholesterol and lipid rafts increases shedding of CD30.

J Immunol 2004 Apr;172(7):4324-31

Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.

View Article
April 2004